Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

SeraCare™ Teragenix HIV Drug Resistance Performance panels

Panel of naturally occurring plasma specimens from HIV-infected individuals whose virus demonstrates multiple drug resistance mutations

Manufacturer:  SeraCare™ 08000251

Catalog No. 22-554-462


Due to product restrictions, please to purchase or view availability for this product.

Alert:

Potentially infectious materials. Follow the Centers for Disease Control (CDC) recommended universal precautions for handling this product. Panel members were tested and most were found positive for HIV-1 RNA. Never pipette by mouth. Do not smoke, eat or drink in areas where specimens are handled. These materials should be disposed of in a manner that will inactivate pathogenic agents.


Description

Description

The panel contains ten naturally occurring plasma samples, each demonstrating multiple reverse transcriptase and protease associated mutations

  • Intended for use to develop, verify or validate HIV drug resistance mutation assays, evaluate new kit lots, assess technician proficiency or compare test methods, using specimens that are reactive for HIV RNA
  • For research use only

  • Extensive array of panels helps labs maintain the highest standards for assay validation, regulatory compliance and method development
  • Each panel includes comprehensive, comparative data from a variety of methods and commercially available test kits, allowing reagent assay/platform performance, sensitivity and specificity to be challenged
  • Assembled from highly characterized, disease state patient samples, and developed specifically for infectious disease testing
  • Enables labs to evaluate, monitor and troubleshoot test and staff performance
  • Minimizes down time and accelerates validation and verification of new test methods, reagent systems and platforms

  • Rigorously tested and characterized using highest-quality test methods
  • Comprehensive test results provided with each panel; quantified against international standards when available
  • Long-term stability and availability
  • SeraCare facilities are ISO 9001 and 13485 certified and comply with cGMP standards

Specifications

Specifications

Teragenix HIV Drug Resistance Performance Panel
Ten naturally occurring Plasma samples, each demonstrating multiple Reverse Transcriptase and Protease associated mutations
-70°C
Used to develop, verify or validate HIV drug resistance mutation assays, evaluate new kit lots, assess technician proficiency or compare test methods, using characterized specimens
Panel
ISO 9001, 13485
10 x 1mL
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit